172 related articles for article (PubMed ID: 20371611)
1. Identification of heterogeneous nuclear ribonucleoprotein K as a transactivator for human low density lipoprotein receptor gene transcription.
Li H; Liu J
J Biol Chem; 2010 Jun; 285(23):17789-97. PubMed ID: 20371611
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter.
Stains JP; Lecanda F; Towler DA; Civitelli R
Biochem J; 2005 Jan; 385(Pt 2):613-23. PubMed ID: 15361071
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.
He L; Xue X; Wang Z; Hou E; Liu Y; Liang M; Zhang Y; Tian Z
Biochimie; 2015 Feb; 109():27-35. PubMed ID: 25497182
[TBL] [Abstract][Full Text] [Related]
4. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function.
Natesampillai S; Fernandez-Zapico ME; Urrutia R; Veldhuis JD
J Biol Chem; 2006 Feb; 281(6):3040-7. PubMed ID: 16303770
[TBL] [Abstract][Full Text] [Related]
5. The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue.
Singh AB; Li H; Kan CF; Dong B; Nicolls MR; Liu J
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):8-16. PubMed ID: 24158514
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear ribonucleoprotein K is a transcription factor.
Michelotti EF; Michelotti GA; Aronsohn AI; Levens D
Mol Cell Biol; 1996 May; 16(5):2350-60. PubMed ID: 8628302
[TBL] [Abstract][Full Text] [Related]
7. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter.
Li C; Kraemer FB; Ahlborn TE; Liu J
J Biol Chem; 1999 Mar; 274(10):6747-53. PubMed ID: 10037774
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous nuclear ribonucleoprotein K and nucleolin as transcriptional activators of the vascular endothelial growth factor promoter through interaction with secondary DNA structures.
Uribe DJ; Guo K; Shin YJ; Sun D
Biochemistry; 2011 May; 50(18):3796-806. PubMed ID: 21466159
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator.
Tomonaga T; Levens D
J Biol Chem; 1995 Mar; 270(9):4875-81. PubMed ID: 7876260
[TBL] [Abstract][Full Text] [Related]
10. Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements.
Li H; Chen W; Zhou Y; Abidi P; Sharpe O; Robinson WH; Kraemer FB; Liu J
J Lipid Res; 2009 May; 50(5):820-31. PubMed ID: 19141871
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous nuclear ribonucleoprotein K modulates angiotensinogen gene expression in kidney cells.
Wei CC; Zhang SL; Chen YW; Guo DF; Ingelfinger JR; Bomsztyk K; Chan JS
J Biol Chem; 2006 Sep; 281(35):25344-55. PubMed ID: 16837467
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.
Chung IC; Chen LC; Chung AK; Chao M; Huang HY; Hsueh C; Tsang NM; Chang KP; Liang Y; Li HP; Chang YS
BMC Cancer; 2014 May; 14():348. PubMed ID: 24885469
[TBL] [Abstract][Full Text] [Related]
13. Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells.
Qiu J; Chen S; Su L; Liu J; Xiao N; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Jul; 1840(7):2244-52. PubMed ID: 24594223
[TBL] [Abstract][Full Text] [Related]
14. Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression.
Li C; Briggs MR; Ahlborn TE; Kraemer FB; Liu J
Endocrinology; 2001 Apr; 142(4):1546-53. PubMed ID: 11250935
[TBL] [Abstract][Full Text] [Related]
15. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
16. Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription.
Ritchie SA; Pasha MK; Batten DJ; Sharma RK; Olson DJ; Ross AR; Bonham K
Nucleic Acids Res; 2003 Mar; 31(5):1502-13. PubMed ID: 12595559
[TBL] [Abstract][Full Text] [Related]
17. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
[TBL] [Abstract][Full Text] [Related]
18. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation.
Lynch M; Chen L; Ravitz MJ; Mehtani S; Korenblat K; Pazin MJ; Schmidt EV
Mol Cell Biol; 2005 Aug; 25(15):6436-53. PubMed ID: 16024782
[TBL] [Abstract][Full Text] [Related]
19. trans-Activation by the hnRNP K protein involves an increase in RNA synthesis from the reporter genes.
Lee MH; Mori S; Raychaudhuri P
J Biol Chem; 1996 Feb; 271(7):3420-7. PubMed ID: 8631943
[TBL] [Abstract][Full Text] [Related]
20. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients.
Chen LC; Chung IC; Hsueh C; Tsang NM; Chi LM; Liang Y; Chen CC; Wang LJ; Chang YS
Cell Death Differ; 2010 Sep; 17(9):1463-73. PubMed ID: 20224598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
